Concord Medical Services Holdings Limited (CCM)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 03:58PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 36.90M |
| Enterprise value | 484.10M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.50 |
| Price/book (mrq) | 3.00 |
| Enterprise value/revenue | 0.90 |
| Enterprise value/EBITDA | -1.85 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.17 |
| 52-week change 3 | -38.85% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 1.6000 |
| 52-week low 3 | 0.3800 |
| 50-day moving average 3 | 0.5448 |
| 200-day moving average 3 | 0.9977 |
Share statistics
| Avg vol (3-month) 3 | 11.67k |
| Avg vol (10-day) 3 | 10.05k |
| Shares outstanding 5 | 43.42M |
| Implied shares outstanding 6 | 43.42M |
| Float 8 | 42.02M |
| % held by insiders 1 | 18.00% |
| % held by institutions 1 | 0.19% |
| Shares short (15 Apr 2024) 4 | 6.93k |
| Short ratio (15 Apr 2024) 4 | 0.37 |
| Short % of float (15 Apr 2024) 4 | 0.03% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.02% |
| Shares short (prior month 15 Mar 2024) 4 | 6.97k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 29 Jan 2016 |
| Ex-dividend date 4 | 23 Dec 2015 |
| Last split factor 2 | 11384:10000 |
| Last split date 3 | 16 Jan 2014 |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -55.39% |
| Operating margin (ttm) | -98.45% |
Management effectiveness
| Return on assets (ttm) | -4.80% |
| Return on equity (ttm) | -28.23% |
Income statement
| Revenue (ttm) | 537.4M |
| Revenue per share (ttm) | 12.30 |
| Quarterly revenue growth (yoy) | -22.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -344.16M |
| Net income avi to common (ttm) | -297.66M |
| Diluted EPS (ttm) | -0.9400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 58.14M |
| Total cash per share (mrq) | 0.45 |
| Total debt (mrq) | 3.3B |
| Total debt/equity (mrq) | 188.65% |
| Current ratio (mrq) | 0.32 |
| Book value per share (mrq) | -48.87 |
Cash flow statement
| Operating cash flow (ttm) | -276.47M |
| Levered free cash flow (ttm) | -51.94M |
© 2024 Yahoo. All rights reserved.